• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机阴离子跨胆小管膜转运活性的种属差异。

Species differences in the transport activity for organic anions across the bile canalicular membrane.

作者信息

Ishizuka H, Konno K, Shiina T, Naganuma H, Nishimura K, Ito K, Suzuki H, Sugiyama Y

机构信息

Analytical and Metabolic Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

出版信息

J Pharmacol Exp Ther. 1999 Sep;290(3):1324-30.

PMID:10454510
Abstract

Species differences in the transport activity mediated by canalicular multispecific organic anion transporter (cMOAT) were examined using temocaprilat, an angiotensin-converting enzyme inhibitor whose biliary excretion is mediated predominantly by cMOAT, and 2,4-dinitrophenyl-S-glutathione, a typical substrate for cMOAT, in a series of in vivo and in vitro experiments. Temocaprilat was infused to examine the biliary excretion rate at steady-state. The in vivo transport clearance values across the bile canalicular membrane, defined as the biliary excretion rate divided by the hepatic unbound concentrations, were 9.8, 39.2, 9.2, 1.1, and 0.8 ml/min/kg for mouse, rat, guinea pig, rabbit, and dog, respectively. The K(m) and V(max) values for ATP-dependent uptake of 2, 4-dinitrophenyl-S-glutathione into canalicular membrane vesicles were 15.0, 29.6, 16.1, 55.8, and 30.0 microM and 0.38, 1.90, 0.15, 0. 47, and 0.23 nmol/min/mg protein, yielding the in vitro transport clearance across the bile canalicular membrane (V(max)/K(m)) of 25.5, 64.2, 9.4, 8.4, and 7.7 for mouse, rat, guinea pig, rabbit, and dog, respectively. A close in vivo and in vitro correlation was observed among animal species for the transport clearance across the bile canalicular membrane. These results suggest that the uptake experiments with canalicular membrane vesicles can be used to quantitatively predict in vivo excretion across the bile canalicular membrane.

摘要

使用替莫卡普利(一种血管紧张素转换酶抑制剂,其胆汁排泄主要由小管多特异性有机阴离子转运体(cMOAT)介导)和2,4-二硝基苯基-S-谷胱甘肽(cMOAT的一种典型底物),通过一系列体内和体外实验研究了由cMOAT介导的转运活性的物种差异。输注替莫卡普利以检查稳态时的胆汁排泄率。跨胆小管膜的体内转运清除率值定义为胆汁排泄率除以肝脏未结合浓度,小鼠、大鼠、豚鼠、兔子和狗的该值分别为9.8、39.2、9.2、1.1和0.8 ml/min/kg。2,4-二硝基苯基-S-谷胱甘肽依赖ATP摄取进入胆小管膜囊泡的K(m)和V(max)值分别为15.0、29.6、16.1、55.8和30.0 microM以及0.38、1.90、0.15、0.47和0.23 nmol/min/mg蛋白,由此得出小鼠、大鼠、豚鼠、兔子和狗跨胆小管膜的体外转运清除率(V(max)/K(m))分别为25.5、64.2、9.4、8.4和7.7。在不同动物物种之间观察到跨胆小管膜的转运清除率在体内和体外具有密切相关性。这些结果表明,使用胆小管膜囊泡进行的摄取实验可用于定量预测跨胆小管膜的体内排泄。

相似文献

1
Species differences in the transport activity for organic anions across the bile canalicular membrane.有机阴离子跨胆小管膜转运活性的种属差异。
J Pharmacol Exp Ther. 1999 Sep;290(3):1324-30.
2
Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).替莫卡普利拉,一种新型血管紧张素转换酶抑制剂,通过一种ATP依赖性主动转运体(cMOAT)经胆汁排泄,而在卫材高胆红素血症突变大鼠(EHBR)中该转运体功能缺陷。
J Pharmacol Exp Ther. 1997 Mar;280(3):1304-11.
3
Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.胆小管多特异性有机阴离子转运体/多药耐药蛋白2介导还原型谷胱甘肽的低亲和力转运。
Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):393-401.
4
Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.普伐他汀在大鼠体内的胆汁排泄:胆小管多特异性有机阴离子转运体介导的排泄途径的作用。
Drug Metab Dispos. 1997 Oct;25(10):1123-9.
5
Multiple transport systems for organic anions across the bile canalicular membrane.多种有机阴离子跨胆小管膜转运系统。
J Pharmacol Exp Ther. 1994 Jan;268(1):65-73.
6
Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.环肽奥曲肽的组织分布及胆汁排泄机制
J Pharmacol Exp Ther. 1996 Dec;279(3):1357-64.
7
Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.在大鼠中,甲氨蝶呤通过胆小管多特异性有机阴离子转运体排泄到胆汁中。
Cancer Res. 1997 Aug 15;57(16):3506-10.
8
Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes.离体培养大鼠肝细胞中胆小管有机阴离子转运活性的重新分布
Hepatology. 1995 Jun;21(6):1649-57.
9
Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.大鼠体内新型抗叶酸剂N-[4-[(2,4-二氨基蝶啶-6-基)甲基]-3,4-二氢-2H-1,4-苯并噻嗪-7-基]羰基-L-高谷氨酸的载体介导肝胆转运
Drug Metab Dispos. 2001 Apr;29(4 Pt 1):394-400.
10
Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.喹诺酮类抗生素格帕沙星及其葡糖醛酸苷在大鼠胆汁排泄中的载体介导机制
J Pharmacol Exp Ther. 1998 Mar;284(3):1033-9.

引用本文的文献

1
Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans.兔、大鼠和人体中呋喃妥因的生理药代动力学模型的建立
Pharmaceutics. 2023 Aug 25;15(9):2199. doi: 10.3390/pharmaceutics15092199.
2
Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.定量蛋白质组学在转化吸收、分布、代谢和排泄及精准医学中的应用。
Pharmacol Rev. 2022 Jul;74(3):769-796. doi: 10.1124/pharmrev.121.000449.
3
Case Study 6: Deconvoluting Hyperbilirubinemia-Differentiating Between Hepatotoxicity and Reversible Inhibition of UGT1A1, MRP2, or OATP1B1 in Drug Development.
案例研究 6:去卷积高胆红素血症——在药物开发中区分肝毒性与 UGT1A1、MRP2 或 OATP1B1 的可逆抑制
Methods Mol Biol. 2021;2342:695-707. doi: 10.1007/978-1-0716-1554-6_25.
4
Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.喷雾干燥微颗粒形式的乙硫异烟胺在豚鼠肺部的药代动力学
J Pharm Sci. 2017 Jan;106(1):331-337. doi: 10.1016/j.xphs.2016.09.033. Epub 2016 Nov 11.
5
Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.利用同位素稀释纳升液相色谱-串联质谱靶向定量蛋白质组学对不同物种肝脏和肾脏中的四种外排药物转运蛋白进行定量分析。
Pharm Res. 2016 Sep;33(9):2280-8. doi: 10.1007/s11095-016-1966-5. Epub 2016 Jun 29.
6
A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Shuang-Huang-Lian Injection in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry.基于超高效液相色谱-四极杆飞行时间质谱的代谢组学方法筛选双黄连注射液人血清原型成分及代谢物
J Anal Methods Chem. 2014;2014:241505. doi: 10.1155/2014/241505. Epub 2014 Feb 26.
7
ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.ABC 转运蛋白在多药耐药和药代动力学中的作用,以及药物开发的策略。
Curr Pharm Des. 2014;20(5):793-807. doi: 10.2174/138161282005140214165212.
8
The liver partition coefficient-corrected inhibitory quotient and the pharmacokinetic-pharmacodynamic relationship of directly acting anti-hepatitis C virus agents in humans.人类直接作用抗丙型肝炎病毒药物的肝分区系数校正抑制商和药代动力学-药效学关系。
Antimicrob Agents Chemother. 2012 Oct;56(10):5381-6. doi: 10.1128/AAC.01028-12. Epub 2012 Aug 6.
9
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.多药耐药蛋白(MRPs/ABCCs)在癌症化疗和遗传疾病中的作用。
FEBS J. 2011 Sep;278(18):3226-45. doi: 10.1111/j.1742-4658.2011.08235.x. Epub 2011 Aug 1.
10
To scale or not to scale: the principles of dose extrapolation.是否需要进行剂量外推:剂量外推的原则。
Br J Pharmacol. 2009 Jul;157(6):907-21. doi: 10.1111/j.1476-5381.2009.00267.x. Epub 2009 Jun 5.